145 related articles for article (PubMed ID: 16714638)
1. Evaluation of primary malignancies of the liver using contrast-enhanced sonography: correlation with pathology.
Fan ZH; Chen MH; Dai Y; Wang YB; Yan K; Wu W; Yang W; Yin SS
AJR Am J Roentgenol; 2006 Jun; 186(6):1512-9. PubMed ID: 16714638
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of hepatocellular carcinoma by contrast-enhanced sonography: correlation with pathologic differentiation.
Xu JF; Liu HY; Shi Y; Wei ZH; Wu Y
J Ultrasound Med; 2011 May; 30(5):625-33. PubMed ID: 21527610
[TBL] [Abstract][Full Text] [Related]
3. Contrast-enhanced sonography for the characterisation of hepatocellular carcinomas--correlation with histological differentiation.
Strobel D; Kleinecke C; Hänsler J; Frieser M; Händl T; Hahn EG; Bernatik T
Ultraschall Med; 2005 Aug; 26(4):270-6. PubMed ID: 16123920
[TBL] [Abstract][Full Text] [Related]
4. Differential patterns of contrast enhancement in different focal liver lesions after injection of the microbubble US contrast agent SonoVue.
Quaia E; Degobbis F; Tona G; Mosconi E; Bertolotto M; Pozzi Mucelli R
Radiol Med; 2004 Mar; 107(3):155-65. PubMed ID: 15031681
[TBL] [Abstract][Full Text] [Related]
5. Contrast-enhanced ultrasound with perflubutane microbubble agent: evaluation of differentiation of hepatocellular carcinoma.
Takahashi M; Maruyama H; Ishibashi H; Yoshikawa M; Yokosuka O
AJR Am J Roentgenol; 2011 Feb; 196(2):W123-31. PubMed ID: 21257852
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of contrast-enhanced ultrasound washout rate in predicting hepatocellular carcinoma differentiation.
Feng Y; Qin XC; Luo Y; Li YZ; Zhou X
Ultrasound Med Biol; 2015 Jun; 41(6):1553-60. PubMed ID: 25747937
[TBL] [Abstract][Full Text] [Related]
7. [Characterization of focal liver lesions with contrast-enhanced low MI real time ultrasound and SonoVue].
Hohmann J; Skrok J; Puls R; Albrecht T
Rofo; 2003 Jun; 175(6):835-43. PubMed ID: 12811698
[TBL] [Abstract][Full Text] [Related]
8. [Early diagnosis of small hepatocellular carcinoma by new contrast-enhanced ultrasound technique].
Chen MH; Dai Y; Yan K; Fan ZH; Wu W; Wang YB; Yin SS; Yang W; Li JY
Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Oct; 37(5):458-62. PubMed ID: 16224512
[TBL] [Abstract][Full Text] [Related]
9. Enhancement patterns of small hepatocellular carcinoma (≤ 30 mm) on contrast-enhanced ultrasound: Correlation with clinicopathologic characteristics.
Fan PL; Ding H; Mao F; Chen LL; Dong Y; Wang WP
Eur J Radiol; 2020 Nov; 132():109341. PubMed ID: 33069987
[TBL] [Abstract][Full Text] [Related]
10. Correlation between SonoVue enhancement in CEUS, HCC differentiation and HCC diameter: analysis of 130 patients with hepatocellular carcinoma (HCC).
von Herbay A; Vogt C; Westendorff J; Häussinger D; Gregor M
Ultraschall Med; 2009 Dec; 30(6):544-50. PubMed ID: 19998208
[TBL] [Abstract][Full Text] [Related]
11. Perfusion Characteristics of Hepatocellular Carcinoma at Contrast-enhanced Ultrasound: Influence of the Cellular differentiation, the Tumor Size and the Underlying Hepatic Condition.
Yang D; Li R; Zhang XH; Tang CL; Ma KS; Guo DY; Yan XC
Sci Rep; 2018 Mar; 8(1):4713. PubMed ID: 29549368
[TBL] [Abstract][Full Text] [Related]
12. [Contrast-enhanced ultrasound in the diagnosis of benign and malignant hepatic tumors].
Jiang Y; Zhou Q; Zhu C
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2012 Jan; 37(1):53-6. PubMed ID: 22349380
[TBL] [Abstract][Full Text] [Related]
13. Differential Diagnosis of Arterial Phase Enhanced Hepatic Inflammatory Lesions and Hepatocellular Carcinomas with Contrast-enhanced Ultrasound.
Yang W; Yan K; Wang S; Dai Y; Wu W; Yin SS; Chen MH
Ultrasound Med Biol; 2016 Jan; 42(1):82-91. PubMed ID: 26456578
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of hepatocellular carcinoma using SonoVue, a second generation ultrasound contrast agent: correlation with cellular differentiation.
Nicolau C; Catalá V; Vilana R; Gilabert R; Bianchi L; Solé M; Pagés M; Brú C
Eur Radiol; 2004 Jun; 14(6):1092-9. PubMed ID: 15007620
[TBL] [Abstract][Full Text] [Related]
15. Correlation between contrast-enhanced intraoperative ultrasound using Sonazoid and histologic grade of resected hepatocellular carcinoma.
Arita J; Hasegawa K; Takahashi M; Hata S; Shindoh J; Sugawara Y; Kokudo N
AJR Am J Roentgenol; 2011 Jun; 196(6):1314-21. PubMed ID: 21606294
[TBL] [Abstract][Full Text] [Related]
16. Value of liver parenchymal phase contrast-enhanced sonography to diagnose premalignant and borderline lesions and overt hepatocellular carcinoma.
Inoue T; Kudo M; Maenishi O; Komuta M; Nakashima O; Kojiro M; Maekawa K
AJR Am J Roentgenol; 2009 Mar; 192(3):698-705. PubMed ID: 19234266
[TBL] [Abstract][Full Text] [Related]
17. Enhancement patterns of hepatocellular carcinoma at contrast-enhanced US: comparison with histologic differentiation.
Jang HJ; Kim TK; Burns PN; Wilson SR
Radiology; 2007 Sep; 244(3):898-906. PubMed ID: 17709836
[TBL] [Abstract][Full Text] [Related]
18. Small hepatocellular carcinomas in cirrhosis: differences in contrast enhancement effects between helical CT and MR imaging during multiphasic dynamic imaging.
Hayashida M; Ito K; Fujita T; Shimizu A; Sasaki K; Tanabe M; Matsunaga N
Magn Reson Imaging; 2008 Jan; 26(1):65-71. PubMed ID: 17566685
[TBL] [Abstract][Full Text] [Related]
19. Contrast-enhanced ultrasound of hepatocarcinogenesis in liver cirrhosis.
Wu W; Chen MH; Sun M; Yan K; Yang W; Li JY
Chin Med J (Engl); 2012 Sep; 125(17):3104-9. PubMed ID: 22932189
[TBL] [Abstract][Full Text] [Related]
20. Prediction of poorly differentiated hepatocellular carcinoma using contrast computed tomography.
Nakachi K; Tamai H; Mori Y; Shingaki N; Moribata K; Deguchi H; Ueda K; Inoue I; Maekita T; Iguchi M; Kato J; Ichinose M
Cancer Imaging; 2014 Apr; 14(1):7. PubMed ID: 25608454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]